Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 9, 2011, Pages 2007-2014

  Patel, Roshan ^a   Janoudi, Abed ^a   Vedre, Ameeth ^a   Aziz, Kusai ^a   Tamhane, Umesh ^a   Rubinstein, Jack ^d   Abela, Oliver G ^a   Berger, Kevin ^b   Abela, George S ^a,c  

^a Division of Cardiology   (United States)

^b Department of Radiology ^*  (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

acute coronary syndromes; arterial thrombosis; atherosclerosis; pathology; positron emission tomography

Indexed keywords

CHOLESTEROL; EZETIMIBE; FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA THROMBOSIS; AORTA WALL; ARTERITIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CRYSTALLIZATION; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RABBIT; SCANNING ELECTRON MICROSCOPE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA; AZETIDINES; C-REACTIVE PROTEIN; CHOLESTEROL; CRYSTALLIZATION; FLUORODEOXYGLUCOSE F18; MALE; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOPHARMACEUTICALS; THROMBOSIS;

EID: 80052144336     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.226167     Document Type: Article

References (30)

1. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res. 1996;6:1-17.
2. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction causing sudden ischaemic death, and crescendo angina. Br Heart J. 1985;53:363-373. (Pubitemid 15055510)
3. Abela GS, Picon PD, Friedl SE, Gebara OC, Federman M, Tofler GH, Muller JE. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation. 1995;91:776-784.
4. Ma H, Aziz KS, Huang R, Abela GS. Arterial wall cholesterol content is a predictor of the development and severity of arterial thrombosis. J Thromb Thrombol. 2006;22:5-11. (Pubitemid 43922996)
5. Aziz K, Berger K, Claycombe K, Huang R, Patel R, Abela GS. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis using CTA/PET. Circulation. 2008;117:2061-2070.
6. Phinikaridou A, Hallock KJ, Qiao Y, Hamilton JA. A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res. 2009;50: 787-797.
7. Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodexoygluscose positron emission tomography. J Nucl Cardiol. 2005;45:1245-1250.
8. Abela GS, Aziz K. Cholesterol crystals rupture biological membranes and human plaques during acute cardiovascular events: a novel insight into plaque rupture by scanning electron microscopy. Scanning. 2006; 28:1-10. (Pubitemid 43221678)
9. Vedre A, Pathak DR, Crimp M, Lum C, Koochesfahani M, Abela GS. Physical factors that trigger cholesterol crystallization leading to plaque rupture. Atherosclerosis. 2009;203:89-96.
10. Abela GS, Aziz K, Vedre A, Pathak D, Talbott JD, Joyce DeJong J. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am J Card. 2009;103: 959-968.
11. Gómez-Garre D, Muñoz-Pacheco P, González-Rubio ML, Aragoncillo P, Granados R, Fernández-Cruz A. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect. B J Pharmacol. 2009;156: 1218-1227.
12. Regitnig P, van Paasen R, Tsybrovskyy O. How to improve microscopic images obtained with consumer-time digital cameras. Histopathology. 2003;42:503-508. (Pubitemid 36605595)
13. Webster P, Webster A. Cryosectioning fixed and cryoprotected biological materials. In: Kuo J II, ed. Electron Microscopy: Methods and Protocols. Totowa, NJ: Humana Press; 2007:257-289. (Pubitemid 350183451)
14. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol. 1984;99:2034-2040. (Pubitemid 15181864)
15. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69: 377-381. (Pubitemid 23171108)
16. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Eng J Med. 2000;343:915-922.
17. Qiao JH, Fishbein MC. The severity of coronary atherosclerosis at sties of plaque rupture with occlusive thrombosis. J AM Coll Card. 1991;17: 1138-1142.
18. Robbie L, Libby P. Inflammation and atherothrombosis. Ann N Y Acad Sci. 2001;947:167-179.
19. Wassélius JA, Larsson SA, Jacobsson H. FDG-accumulating atherosclerotic plaques identified with 18F-FDG-PET/CT in 141 patients. Mol imaging Biol. 2009;11:455-459.
20. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnstrom P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD, Weissberg PL. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002; 105:2708-2711. (Pubitemid 34615139)
21. Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. J Nucl Med. 2009;50:959-965.
22. Rudd JH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M, Tahara N, Fuster V, Warburton EA, Fayad ZA, Tawakol AA. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol. 2010; 55:2527-2535.
23. Avart SJ, Bernard DW, Jerome WG, Glick JM. Cholesteryl ester hydrolysis in J774 macrophages occurs in the cytoplasm and lysosomes. J Lipid Res. 1999;405:405-414. (Pubitemid 29116143)
24. Tangirala RK, Jerome WG, Jones NL, Small DM, Johnson WJ, Glick JM, Mahlberg FH, Rothblat GH. Formation of cholesterol monotydrate crystals in macrophage-derived foam cells. J Lipid Res. 1994;35:93-104. (Pubitemid 24027995)
25. Calcagno C, Cornily J-C, Hyafil F, Rudd JHF, Briley-Saebo KC, Mani V, Goldschlager G, Machac J, Fuster V, Fayad ZA. Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterio Thromb Vasc Biol. 2008;28:1311-1317.
26. Düewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunũez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357-1362.
27. Geng Y-J, Phillips JE, Mason RP, Casscells SW. Cholesterol crystallization and macrophage apoptosis: implication for atherosclerotic plaque instability and rupture. Biochem Pharm. 2003;66:1485-1492. (Pubitemid 38373337)
28. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic activity. Arterioscler Thromb Vasc Biol. 2005;25:2255-2264. (Pubitemid 41552640)
29. Abela GS. Cholesterol crystal piercing the arterial plaque and intima triggers local and systemic inflammation. J Clin Lipidol. 2010;4: 156-164.
30. LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, Wenger NK; Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352: 1425-1435. (Pubitemid 40471450)